L'intérêt à découvert pour ProShares Smart Materials ETF donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de ProShares Smart Materials ETF. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

ProShares Smart Materials ETF (ARCA:TINT), Rapport sur les intérêts à découvert

Basic Materials

Technology

Industrials

Other

Healthcare

The Fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the Index. The Index selects companies focused on making or applying industrial innovations which allow for improved products, processes, or techniques through advanced, responsive, or intelligent materials.

Universal Display Corp

3m Co.

Corning Inc

Axalta Coating Systems Ltd.

Dupont De Nemours Inc

Cabot

Applied Materials, Inc.

Sika Ag

Hexcel Corp

Lg Display Co Ltd

Proshares Smart Materials ETF

ProShares Smart Materials ETF

TINTIC STANDARD GLD MNS by Tintic Standard Gold Mines, Inc.

Tintina Mines Ltd

Tintra PLC

Tintri Inc

Have you ever wondered how much money it really takes to be among the top <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">5% of earners in the U.S.</a>? It's a question many people ask, especially as income levels seem to grow further apart.&nbsp;
So, what does it take to rank among the highest earners? The exact amount depends on where you live, but generally speaking, you'd need to earn between $290,000 and $343,000 a year to make the cut.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>
But that number <a href="https://www.benzinga.com/personal-finance/24/09/41102547/is-your-income-higher-than-the-average-middle-class-household-heres-what-theyre-earning">isn't set in stone across the country</a>. For example, in states like Massachusetts, you must pull over $393,000 annually to join the top 5%. Meanwhile, the threshold is much lower in places like Mississippi or West Virginia, at around $170,000. Location plays a big role in how far your money goes.
Remember that these figures are all before taxes and when you add in the cost of living, those numbers can look very different. A $300,000 salary might stretch further in a small town than in New York City or San Francisco. In those cities, it might not even feel like you're part of the top 5% due to the higher expenses.
Now, getting into this <a href="https://www.benzinga.com/personal-finance/24/10/41146426/can-you-guess-the-top-5-careers-of-millionaires-according-to-dave-ramsey-spoiler-alert-theyre-no">top tier doesn't usually happen overnight</a>. Many top 5% earners are in their 40s, 50s or early 60s after years of building their careers. Many have advanced degrees or specialized skills that take time to develop. Data shows that Gen X holds the highest median income in the country. Statista reported that in 2022, individuals aged 45-54 had the highest median household income in the U.S., reaching $101,500.&nbsp;
Trending: Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a>
Unfortunately, there's still a big difference in income across racial and ethnic groups, with Asian Americans leading the way in median earnings at just under $107,000 a year.
If you're wondering about the next step up – <a href="https://www.benzinga.com/personal-finance/24/10/41193824/are-you-rich-enough-to-be-in-the-top-1-heres-both-the-income-and-net-worth-you-need-to-rank-amon">the top 1% – </a>that's a different ballgame. To get there, you'd need to earn around $787,000 annually. The gap between the top 5% and the top 1% shows how steep the income ladder can get.
But here's the thing: making it into the top 5% isn't the only measure of financial success. Whether aiming for that level or working your way up, what matters more is how you manage your money, make smart choices and plan for the future. A big paycheck is great, but financial security comes from ensuring your money works for you.
Ultimately, it's not just about how much you earn but what you do with it. Whether you're already in the top 5% or still climbing, <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">smart financial habits</a> and clear goals are the keys to success.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
<li><a href="https://www.benzinga.com/money/irs-finalizes-10-year-rule-adv">IRS Finalizes 10-Year Rule For Retirement Withdrawals, Making Things &#8216;Even More Insanely Complicated&#8217;</a></li>
</ul>

Personal Finance

Are You Among The Top 5% Of Earners? Here's The Income You Need

In the current market session, Carrier Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) stock price is at $80.97, after a 0.50% drop. However, over the past month, the company's stock increased by 0.26%, and in the past year, by 72.06%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1729625461_0.png" alt="Past Year Chart" />

<h3>Carrier Global P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Carrier Global has a lower P/E than the aggregate P/E of 29.17 of the Building Products industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729625461_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

CARR

Price Over Earnings Overview: Carrier Global

Looking into the current session, Plains All American Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) shares are trading at $17.05, after a 0.35% decrease. Over the past month, the stock decreased by 5.40%, but over the past year, it actually went up by 10.29%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1729625455_0.png" alt="Past Year Chart" />

<h3>A Look at Plains All American P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 16.37 in the Oil, Gas &amp; Consumable Fuels industry, Plains All American Inc. has a lower P/E ratio of 15.41. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729625455_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

P/E Ratio Insights for Plains All American

On Tuesday,&nbsp;Danaher Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41449367/life-science-giant-danaher-q3-earnings-revenue-and-eps-beat-sticks-to-annual-guidance" rel="noreferrer noopener">consensus of $5.59 billion</a>.&nbsp;
Guidance: Danaher reaffirms that in fiscal year 2024, non-GAAP core revenue will be down in the low single digits year over year.
The company forecasts that 2024 bioprocessing core revenue will decline in the low single digits, and Cepheid 2024 respiratory revenues will be around&nbsp;$1.7 billion compared to prior guidance of $1.6 billion.
William Blair reports that Danaher&#8217;s third-quarter earnings aligned with expectations, particularly regarding the ongoing recovery in bioprocessing, though capital expenditures remain weak.
The analyst highlights that the recovery theme is progressing as anticipated, with results reflecting similar trends seen in industry conference updates earlier in the quarter.
Third-quarter book-to-bill improved to approximately 1.0x, up from 0.80x a year ago, and a high-single-digit increase in sequential orders further supported the bioprocessing rebound.
In the equipment segment, life sciences instruments saw a mid-single-digit decline, in line with forecasts and intra-quarter observations.
Meanwhile, diagnostics performed well, and Cepheid&#8217;s respiratory revenue again exceeded expectations.
On guidance, management expects mid- to high-single-digit core growth in the fourth quarter in Biotechnology. The analyst expects the focus of the call will be on the fourth-quarter exit rate for bioprocessing, any initial insights into 2025, capital equipment weakness, and updated thoughts on China.
William Blair keeps the Outperform rating. Goldman Sachs maintains a Neutral rating,<a href="https://www.benzinga.com/quote/dhr/analyst-ratings"> with a price target of $250.</a>
Price Action: DHR stock is down 4.01% at $261.18 at last check Tuesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41462205/with-fda-approval-irhythm-may-be-able-to-lift-regulatory-overhang-investor-skeptici" target="_blank" rel="noreferrer noopener">With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says</a>.</li>
</ul>

Analyst Color

Earnings

Equities

Guidance

Health Care

Price Target

Reiteration

Analyst Ratings

Trading Ideas

General

Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating

Jefferies analyst John Colantuoni has raised price targets on Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) ahead of earnings in the coming weeks. Here&#8217;s what <a href="https://www.benzinga.com/analyst-stock-ratings">you need to know</a>.
Jefferies On UBER: Colantuoni maintained a Buy rating on Uber on Tuesday and raised the price target from $100 to $105.
Colantuoni&#8217;s expectations for Uber&#8217;s <a href="https://www.benzinga.com/calendars/earnings">upcoming earnings report</a> remain high, as he believes the company is somewhat shielded from macroeconomic trends due to its skew toward high-income customers. 
In addition, the analyst anticipates strong EBITDA and ride bookings results, which he believes will enhance confidence in the company&#8217;s ability to achieve its three-year outlook and justify a higher multiple. 
In the company&#8217;s most recent quarter, Uber guided for adjusted EBITDA of $1.58 billion to $1.68 billion and gross bookings between $40.25 billion and $41.75 billion for the third quarter. 
Colantuoni also noted that he&#8217;s on the lookout for further insights into the company&#8217;s autonomous vehicle partnerships. The analyst anticipates a renewed focus on Uber&#8217;s fundamentals following Tesla&#8217;s &#8220;underwhelming&#8221; robotaxi event. 
Related Link: <a href="https://www.benzinga.com/markets/equities/24/10/41445510/tesla-shareholders-demand-answers-from-elon-musk-on-growing-list-of-promises-ahead-of-q3-earning">Tesla Shareholders Demand Answers From Elon Musk On Growing List Of Promises Ahead Of Q3 Earnings: From Affordable Models To FSD Rollout And Next-Generation Roadster</a>
Uber is due to report earnings for the third quarter on Oct. 31. Analysts expect Uber to report EPS of 39 cents and revenue of $10.97 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Jefferies On LYFT: Colantuoni maintained a Hold rating on Lyft and raised the price target from $10.50 to $13.
Lyft is scheduled to report earnings on Nov. 6. The company is expected to report EPS of 19 cents and revenue of $1.44 billion for the third quarter, according to <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates.
Colantuoni said he will be watching for evidence that Lyft can maintain market share over time, especially after the company issued &#8220;aggressive&#8221; three-year targets at its Investor Day earlier this year.
&#8220;We believe the market will otherwise remain skeptical of a 3-year outlook that assumes limited pricing growth and implies Gross Margin expansion is dependent on increased Media penetration (and lower incentives) to offset insurance inflation, despite mobility advertising being relatively nascent,&#8221; the analyst said.
Lyft&#8217;s guidance for the third-quarter included expected gross bookings of $4 billion to $4.1 billion and adjusted EBITDA between $90 million and $95 million. Colantuoni said he will also be watching for bookings and EBITDA guidance moving forward, mobility trends and pricing, marketing spend, impacts of insurance renewals and any robotaxi commentary.
Price Action: At the time of writing, Lyft stock was down 1.92% at $13.77 and Uber stock was down 0.11% at $80.27, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41372597/elon-musk-isnt-the-only-one-chasing-super-app-dominance-in-the-us-uber-ceo-eyes-a-slice-with-potenti">Elon Musk Isn&#8217;t The Only One Chasing &#8216;Super App&#8217; Dominance In The US— Uber CEO Eyes A Slice With Potential Expedia Acquisition</a></li>
</ul>
Image: Shutterstock.

Movers

LYFT

UBER

Jefferies Raises Targets On Uber, Lyft Shares Ahead Of Q3 Earnings

<a href="https://www.marijuanamoment.net/legislative-committee-in-ireland-calls-for-marijuana-legalization-and-decriminalization-of-all-illicit-drugs/">https://www.marijuanamoment.net/legislative-committee-in-ireland-calls-for-marijuana-legalization-and-decriminalization-of-all-illicit-drugs/</a>
After lawmakers in Ireland <a href="https://www.marijuanamoment.net/irelands-government-proposes-nine-month-delay-on-marijuana-legalization-bill-vote-calling-for-special-committee/">delayed a vote on marijuana legalization earlier this year</a> in favor of further studying the issue, a special legislative committee on drug policy has published an interim report with nearly 60 recommendations, calling for changes such as the limited legalization of marijuana and the decriminalization of personal use and possession of all illegal drugs.
The new report, released on Tuesday, is the product of the Oireachtas Joint Committee on Drugs Use, which was formed to consider cannabis legalization and other drug policy issues following the release of a <a href="https://www.marijuanamoment.net/as-irish-lawmakers-prepare-to-debate-marijuana-bill-prime-minister-pledges-to-examine-drug-decriminalization-as-recommended-by-citizen-commission/">citizen commission report in January that recommended broadly decriminalizing drugs</a>&nbsp;and implementing harm reduction programs.
Gino Kenny, the chair of the committee and a member of Ireland's lower house of parliament, <a href="https://www.irishexaminer.com/news/arid-41501180.html">told</a> Irish Examiner that the proposal could allow cannabis clubs where members can purchase small amounts of marijuana grown on a nonprofit basis, which <a href="https://www.marijuanamoment.net/german-officials-approve-countrys-first-marijuana-social-club-since-legalization-took-effect/">some other European countries permit</a>, but may also allow for broader commercial legalization.
"It's important that this is implemented," Kenny told the paper, emphasizing his perspective that the government should adopt a "health-led approach" to drug use.
&nbsp;
Indeed, many of the 59 recommendations from the special committee focus on shifting the paradigm around drug control from one of punishment and stigma to one of health and harm reduction. That's the core of the first six recommendations laid out in the committee's description of its interim report, which includes findings that "the stigmatisation of drug use and the shaming of drug users are a source of significant harm" and that "the goal of drug policy should be to reduce harm and eliminate stigma."
To that end, it says, "the decriminalization of possession for personal use should apply equally to all illicit drugs." And while "people should be offered all supports and health resources that are required," it adds, "no person should be criminalised for not availing of a supportive intervention."
When it comes to marijuana, the committee is calling on health and justice officials to "undertake a body of research into how a regulated drug market could operate in Ireland beginning with cannabis, and how Ireland can incorporate and implement the learnings of other jurisdictions that have taken positive steps in this regard."
The report specifies that the country should consider reforms "with particular reference to Spain, Malta, and Germany in the development of an Irish not for profit regulated cannabis market."
The body is also calling for expansion of the country's medical marijuana program "to ensure that more people affected by chronic illness can access cannabis in circumstances where other treatments have failed to relieve symptoms."
The recommendations also advise that local authorities and An Garda Síochána—the country's national police force—"are supported and empowered in strongly discouraging and reducing consumption in public areas." The committee suggested that "specific trauma and harm reduction training be provided to An Garda Síochána and local authorities, to inform their work with individuals and communities affected by drug misuse and addiction."
Kenny, the committee chair, noted that the body's <a href="https://www.oireachtas.ie/en/press-centre/press-releases/20241022-joint-committee-on-drugs-use-publishes-interim-report-with-59-recommendations/">recommendations</a> are "very clear that the supply and sale of drugs should remain illegal" and acknowledged that drugs can cause "huge damage" to individuals, families and communities, especially among already disadvantaged groups. But he said the committee was in broad agreement that criminalizing substances is the wrong approach.
"There's still a lot to look at of course, but between the work done by the Committee and the Citizens' Assembly, it's clear that there is a consensus that criminalising and prosecuting the use of drugs for personal drug use is a waste of money and is very detrimental to anyone convicted," he said in a statement.
After months of study, he added, "there's no excuse for a new Government to say that issues around the decriminalisation of drugs for personal use haven't been discussed properly. Both the Citizens' Assembly and the Oireachtas Joint Committee on Drugs Use have looked at the issue in detail."
When the committee was first being formed, Ryan McHale, executive committee member of the Irish drug policy reform organization Crainn, told Marijuana Moment that he felt the extra step was a "delay tactic from the Irish Government," which he called "disappointing given the clear calls from the Citizens' Assembly and overwhelming public support for the measure."
"The government are aware of the overwhelming support which is why they didn't outright oppose the bill like they did in 2013, which was the last attempt to liberalize cannabis laws," McHale said. "While there appears to be a shift from government in terms of changing Ireland's drug laws, they have not yet committed to any substantial legal change."
"This delay will mean that hundreds of people will be criminalized for personal possession of cannabis while the Irish government ponder the political effectiveness of reform," he added. "We cannot wait anymore and the Citizens' Assembly have been clear in their calls for change to the harmful status quo."
TD Paul Murphy said the government's proposed delay is "simply an attempt to kick the can down the road."
"They talk about a health led approach to drugs," he said. "Now it's time to walk the walk."
The cannabis legalization bill from Kenny that prompted the committee's formation was first introduced in 2022.
Ireland's taoiseach—or prime minister—Leo Varadkar <a href="https://www.marijuanamoment.net/as-irish-lawmakers-prepare-to-debate-marijuana-bill-prime-minister-pledges-to-examine-drug-decriminalization-as-recommended-by-citizen-commission/">told lawmakers earlier this year that he agrees prohibition doesn't work</a>, as evidenced by prohibition periods in Ireland that created illicit markets with "impure" alcohol products.
"In my view, drug use and misuse by individuals should be seen primarily as a public health issue and not a criminal justice matter," Varadkar said. "I certainly think that shaming people and blaming people and criminalizing people isn't an effective policy."
The Citizens' Assembly on Drugs Use considered marijuana legalization as part of its work last year, but a <a href="https://www.marijuanamoment.net/irish-citizens-panel-votes-to-recommend-decriminalizing-drug-possession-but-marijuana-legalization-falls-one-vote-short/">recommendation to enact the reform came up short by one vote</a>.
A year ago, the citizens' group posted summaries of 36 policy recommendations online—the culmination of what the body's chair, Paul Reid, called "the most comprehensive, wide-ranging, and representative discussion on all aspects of drugs use and drugs policy that has ever taken place in Ireland."
The group's overarching message, Reid said in a statement at the time, was that lawmakers must "take a much more ambitious and progressive approach to dealing with drugs in Ireland."
"Ultimately, it will be up to the Oireachtas to implement what the Assembly has called for," he said, referring to Ireland's national parliament. "But if they do, this will not only change the national policy and approach, it will also change people's lives. For the better."

Global

AKAN

CRON

iShares MSCI Ireland Capped Investable Market Index Fund

EIRL

GRWG

IMCC

LFLY

MAPS

MSOS

SNDL

TLRY

"Legislative Committee In Ireland Calls For Marijuana Legalization And Decriminalization Of 'All Illicit Drugs'" - Marijuana Moment

Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) shares are trading higher by 9% to $765.66 over the past week. The stock hit a new 52-week high after last week reporting better-than-expected <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">third-quarter financial results</a> and 14.4% growth in global streaming paid memberships.
Additionally, according to an earlier WSJ report, Netflix has closed its Southern California game studio, Team Blue, just under a year after its establishment, signaling a major change in the <a href="https://www.benzinga.com/general/gaming/24/10/41462659/netflix-ends-aaa-game-development-at-california-studio">company&#8217;s gaming strategy</a> following the exit of key executives.
What Happened With Earnings: Netflix saw its stock soar to new all-time highs last week following the release of its impressive third-quarter financial results after market close on Thursday. 
The streaming giant reported revenue of $9.825 billion, reflecting a 15% year-over-year increase and surpassing analysts' expectations of $9.769 billion. Additionally, the company achieved EPS of $5.40, beating the consensus estimate of $5.12.
As of the end of September, Netflix boasted 282.72 million global paid subscribers, up 14.4% from the previous year. The addition of 5.07 million new subscribers during the quarter, while lower than last year's 8.8 million, still underscores the company&#8217;s ongoing appeal in a competitive market. Subscriber engagement also remained strong, with members averaging approximately two hours of viewing per day.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/24/10/41461948/boeing-stock-braces-for-bumpy-q3-landing">Boeing Stock Braces For Bumpy Q3 Landing</a>
Notably, Netflix&#8217;s ad-supported subscription model showed promise, with membership increasing by 35% quarter-over-quarter and accounting for over 50% of new sign-ups. The company plans to enhance its ad-tech offerings, aiming for a broader rollout in 2025.
What Else: Looking ahead, Netflix projected fourth-quarter revenue of $10.128 billion, a 14.7% increase year-over-year, and an EPS of $4.23, compared to $2.11 in the same period last year. 
With a slate of exciting content lined up—including the boxing match between Jake Paul and Mike Tyson and a new season of &#8220;Squid Game&#8221;—the company anticipates a boost in subscriber growth and engagement during the critical holiday season.
The company also provided a bullish long-term outlook, forecasting revenue between $43 billion and $44 billion by 2025.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/10/41462140/stocks-fall-gm-eyes-best-day-in-a-year-gold-breaks-records-silver-hits-12-year-highs-whats-driving-">Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What&#8217;s Driving Markets Tuesday?</a>
<h2 class="wp-block-heading">Is NFLX A Good Stock To Buy?</h2>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages &#8211; like <a href="https://www.benzinga.com/quote/NFLX">Netflix</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. Netflix does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's <a href="https://www.benzinga.com/calendars/dividends">dividend calendar</a> for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you're looking to earn an annualized return of 11.25%, you'll need to buy a share of First Trust Senior by the Nov. 1, 2024. Once done, you can expect to receive a nominal payout of $0.1 on Nov. 15, 2024.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/NFLX">Netflix</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, NFLX has a 52-week high of $773.00 and a 52-week low of $395.62.

NFLX

What's Going On With Netflix Stock?

BioSig Technologies, Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#OTCQB">BSGM</a>) ("BioSig" or the "Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced its successful appeal to the NASDAQ Panel, and as a result the Company's common stock will resume trading on the NASDAQ Capital Market Exchange at the open of trading on Wednesday, October 23, 2024. The Company was granted an extension until March 7, 2025, a 360-day grace period from the point at which the Market Value of Listed Securities ("MVLS") requirement previously became non-compliant.

BSGM

BioSig Technologies' Common Stock To Resume Trading On The Nasdaq Exchange, Wednesday, October 23, 2024 After Its Appeal Was Granted An Extension Until March 7, 2025

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 0.2% on Tuesday.
The Dow traded up 0.08% to 42,963.84 while the NASDAQ gained 0.18% to 18,573.16. The S&amp;P 500, however, fell 0.02% to 5,852.75 during the session.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41426981/top-4-consumer-stocks-that-may-dip-this-quarter">Top 4 Consumer Stocks That May Dip This Quarter</a>
Leading and Lagging Sectors Consumer staples shares rose by 0.8% on Tuesday.
In trading on Monday, industrials shares fell by 1%.
Top Headline
Shares of Verizon Communications Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) fell around 5% on Tuesday after it reported fiscal third-quarter results.
Its sales growth was flat year over year, reaching $33.33 billion, marginally missing the analyst consensus estimate of $33.43 billion. Service and other revenue growth was offset by declines in wireless equipment revenue. Adjusted EPS of $1.19 beat the analyst consensus estimate of $1.18.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) shares shot up 22% to $75.59 after the company announced that it was granted FDA clearance for its 510(k) submission related to prior design changes made to the Zio AT device.</li>
<li>Shares of Mueller Industries, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) got a boost, surging 16% to $83.35 after the company reported better-than-expected third-quarter sales results.</li>
<li>Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) shares were also up, gaining 37% to $1.2499 after the company announced the FDA approved an accelerated pathway for ST-920 in Fabry disease. A BLA submission is expected in 2025.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) shares dropped 19% to $115.37 after the company reported mixed third-quarter financial results and cut its FY24 EPS below estimates.</li>
<li>Shares of Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) were down 8% to $73.50 after the company reported worse-than-expected third-quarter EPS and sales and cut its 2024 guidance.</li>
<li>Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) was down, falling 8% to $84.04 following second-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 2.1% to $72.06 while gold traded up 0.8% at $2,761.40.
Silver traded up 2.9% to $35.050 on Tuesday, while copper rose 0.7% to $4.3890.
Euro zone
European shares closed mostly lower today. The eurozone's STOXX 600 fell 0.21%, Germany's DAX fell 0.20% and France's CAC 40 fell 0.01%. Spain's IBEX 35 Index fell 0.07%, while London's FTSE 100 fell 0.14%.
Passenger car registrations in the European Union fell by 6.1% year-over-year to 809,163 units in September following a 18.3% decline in August.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 falling 1.39%, Hong Kong's Hang Seng Index gaining 0.1%, China's Shanghai Composite Index gaining 0.54% and India's BSE Sensex falling 1.15%.
The annual inflation rate in Hong Kong fell to 2.2% in September from 2.5% in the prior month.
Economics
The composite manufacturing index in the US Fifth District came in at -14 for October compared to a reading of -21 in the prior month.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41453972/top-3-defensive-stocks-that-may-keep-you-up-at-night-this-month">Top 3 Defensive Stocks That May Keep You Up At Night This Month</a></li>
</ul>

IRTC

LOGI

SGMO

Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results

The Street loves General Motors Company&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) earnings. The stock is rallying and appears <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41462946/general-motors-strong-q3-earnings-impress-analysts-highlights-turnaround-and-ev-pro">to be breaking out.</a>
This is why Benzinga has made it the &#8220;Stock of the Day.&#8221;
When a stock is heading higher, the market is out of equilibrium. There isn't enough supply to fill all the demand. In other words, there are more buy orders than there are sell orders.
As a result, investors and traders who wish to acquire shares are forced to bid premiums to draw sellers into the market. They need to be willing to pay a higher price than the one at which the prior trade was executed. This can force the shares into an uptrend.
When a stock reaches a resistance level, the dynamic changes. There is more than enough supply to fill all the demand, so buyers can buy as many shares as they want without worrying about increasing the price.
Sometimes, stocks reverse and move lower after they reach resistance. As you can see on the chart, this is what happened with General Motors when it reached the resistance at $50 in July, August, and September.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="630" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/22150456/gm-chart2-1024x630.png" alt="" class="wp-image-608178" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/22150456/gm-chart2-1024x630.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/22150456/gm-chart2-300x185.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/22150456/gm-chart2-768x473.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/22150456/gm-chart2.png 1186w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This action occurs when some of the sellers get nervous. They don't want to miss the trade and know that the buyers will go to whoever is willing to sell at the lowest price. As a result, they reduce the prices for which they are willing to sell their shares.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/10/41462140/stocks-fall-gm-eyes-best-day-in-a-year-gold-breaks-records-silver-hits-12-year-highs-whats-driving-">Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What&#8217;s Driving Markets Tuesday?</a>
Other nervous sellers see this, and they also reduce the prices at which they are willing to sell. This results in a snowball effect, pushing the price lower.
But sometimes, when a stock reaches a resistance level, it can push through it and move higher. Traders call this a breakout, and <a href="https://www.benzinga.com/quote/GM">General Motors</a> may be staging one now.
As you can see on the chart, the shares are trading above what had been resistance at the $50 level. This illustrates a potentially important supply and demand dynamic. 
It could mean that the investors and traders who created the resistance with their sell orders are out of the market. They have finished or canceled their orders.
With this supply gone, buyers may be forced to bid higher prices to attract potential sellers&#8217; attention, which could result in a new uptrend forming.
Breakouts tend to illustrate bullish dynamics, and shares of General Motors may be about to head higher.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41462955/federal-rescheduling-is-not-enough-says-industry-executive-policy-change-urgently-needed">Federal Rescheduling Is &#8216;Not Enough,&#8217; Says Industry Executive, Policy Change Urgently Needed</a></li>
</ul>
Photo: Shutterstock

Technicals

Stock Of The Day: GM Earnings Fuel Breakout, Shares Accelerate Past Key Resistance Level

ADMA Biologics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NYSE">ADMA</a>) short percent of float has risen 37.52% since its last report. The company recently reported that it has 17.08 million shares sold short, which is 7.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.81 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>ADMA Biologics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729624521_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for ADMA Biologics has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing ADMA Biologics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, ADMA Biologics's peer group average for short interest as a percentage of float is 15.05%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

ADMA

(ADMA) - Analyzing ADMA Biologics's Short Interest

SiteOne Landscape Supply's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SITE#NYSE">SITE</a>) short percent of float has fallen 9.2% since its last report. The company recently reported that it has 2.29 million shares sold short, which is 5.82% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.87 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>SiteOne Landscape Supply Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729624516_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for SiteOne Landscape Supply has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing SiteOne Landscape Supply's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, SiteOne Landscape Supply's peer group average for short interest as a percentage of float is 4.25%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

SITE

(SITE) - Analyzing SiteOne Landscape Supply's Short Interest

Dollar Tree's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NYSE">DLTR</a>) short percent of float has fallen 11.35% since its last report. The company recently reported that it has 11.77 million shares sold short, which is 6.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.68 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Dollar Tree Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729624511_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Dollar Tree has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Dollar Tree's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Dollar Tree's peer group average for short interest as a percentage of float is 3.29%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

DLTR

How Is The Market Feeling About Dollar Tree?

Oct 22 (Reuters) -Amgen AMGN.O will launch its biosimilar version of Regeneron's REGN.O blockbuster eye care drug Eylea following a U.S. appeals court ruling in its favor on Tuesday, an Amgen spokesperson said.
The U.S. Court of Appeals for the Federal Circuit rejected Regeneron's request to temporarily block the launch during its appeal of a related decision for Amgen in a patent case in West Virginia.
Spokespeople for Regeneron did not immediately respond to a request for comment on the decision. Eylea earned Regeneron $5.89 billion in U.S. sales in 2023.

Biotech

AMGN

REGN

'Amgen To Launch US Eylea Biosimilar After Ruling In Regeneron Patent Case' - Reuters News

WIIM

LAAC

Shares of lithium companies are trading higher. Strength in the commodity may be due to a recent report suggesting Arkansas could have large lithium reserves.

Immutable's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">IMX</a>) price has decreased 3.52% over the past 24 hours to $1.5, continuing its downward trend over the past week of -5.0%, moving from $1.58 to its current price. 
The chart below compares the price movement and volatility for Immutable over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1729623821_0.png" alt="price_chart" />
The trading volume for the coin has decreased 31.0% over the past week, while the overall circulating supply of the coin has increased 0.03% to over 1.64 billion. This puts its current circulating supply at an estimated 81.89% of its max supply, which is 2.00 billion. The current market cap ranking for IMX is #42 at $2.45 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1729623821_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$IMX

Cryptocurrency Immutable Down More Than 3% Within 24 hours

Kaiser Aluminum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-10-23. Here's what investors need to know before the announcement.
Analysts estimate that Kaiser Aluminum will report an earnings per share (EPS) of $0.84. 
Kaiser Aluminum bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings History Snapshot</h3>
During the last quarter, the company reported an EPS missed by $0.26, leading to a 15.87% drop in the share price on the subsequent day.
Here's a look at Kaiser Aluminum's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.91</td>
<td>0.57</td>
<td>-0.12</td>
<td>0.50</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.65</td>
<td>1.02</td>
<td>0.60</td>
<td>0.46</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-16.0%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729623795_0.png" alt="eps graph" />
<h3>Performance of Kaiser Aluminum Shares</h3>
Shares of Kaiser Aluminum were trading at $70.71 as of October 21. Over the last 52-week period, shares are up 14.09%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/KALU/earnings">To track all earnings releases for Kaiser Aluminum visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KALU

Insights Ahead: Kaiser Aluminum's Quarterly Earnings

QuantumScape (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect QuantumScape to report an earnings per share (EPS) of $-0.21.
Anticipation surrounds QuantumScape's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Overview of Past Earnings</h3>
In the previous earnings release, the company missed EPS by $0.03, leading to a 7.77% drop in the share price the following trading session.
Here's a look at QuantumScape's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.22</td>
<td>-0.21</td>
<td>-0.34</td>
<td>-0.30</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.25</td>
<td>-0.24</td>
<td>-0.23</td>
<td>-0.23</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-8.0%</td>
<td>-7.000000000000001%</td>
<td>-6.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729623787_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of QuantumScape were trading at $5.2 as of October 21. Over the last 52-week period, shares are down 6.06%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/QS/earnings">To track all earnings releases for QuantumScape visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of QuantumScape's Earnings

Western Union (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>) is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Western Union to report an earnings per share (EPS) of $0.44.
Investors in Western Union are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.01 in the last quarter, leading to a 8.33% drop in the share price on the following day.
Here's a look at Western Union's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.45</td>
<td>0.41</td>
<td>0.37</td>
<td>0.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.44</td>
<td>0.45</td>
<td>0.37</td>
<td>0.43</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-8.0%</td>
<td>-2.0%</td>
<td>-6.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729623776_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Western Union were trading at $11.59 as of October 21. Over the last 52-week period, shares are down 10.36%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analyst Insights on Western Union</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Western Union.
With 2 analyst ratings, Western Union has a consensus rating of Neutral. The average one-year price target is $13.0, indicating a potential 12.17% upside.
<h3>Peer Ratings Comparison</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Euronet Worldwide, StoneCo and Payoneer Global, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Euronet Worldwide is maintaining an Buy status according to analysts, with an average 1-year price target of $123.0, indicating a potential 961.26% upside.</li>
<li>As per analysts' assessments, StoneCo is favoring an Neutral trajectory, with an average 1-year price target of $13.0, suggesting a potential 12.17% upside.</li>
<li>The consensus outlook from analysts is an Buy trajectory for Payoneer Global, with an average 1-year price target of $9.06, indicating a potential 21.83% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary outlines pivotal metrics for Euronet Worldwide, StoneCo and Payoneer Global, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Western Union</td>
<td>Neutral</td>
<td>-8.85%</td>
<td>$402.50M</td>
<td>33.62%</td>
</tr>
<tr>
<td>Euronet Worldwide</td>
<td>Buy</td>
<td>5.02%</td>
<td>$405.40M</td>
<td>6.76%</td>
</tr>
<tr>
<td>StoneCo</td>
<td>Neutral</td>
<td>11.86%</td>
<td>$2.25B</td>
<td>3.29%</td>
</tr>
<tr>
<td>Payoneer Global</td>
<td>Buy</td>
<td>15.86%</td>
<td>$202.56M</td>
<td>4.87%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Western Union is positioned in the middle among its peers for revenue growth. It ranks at the top for gross profit. In terms of return on equity, it is also positioned in the middle.
<h3>Delving into Western Union's Background</h3>
Western Union provides domestic and international money transfers through its global network of about 600,000 outside agents. The company handled over 270 million transactions in 2023 and is the largest money transfer company in the world.
<h3>Financial Milestones: Western Union's Journey</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Western Union's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -8.85%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Western Union's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 13.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Western Union's ROE excels beyond industry benchmarks, reaching 33.62%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.76%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 5.98, Western Union faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/WU/earnings">To track all earnings releases for Western Union visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Western Union

Ribbon Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>) is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ribbon Comms to report an earnings per share (EPS) of $0.06.
The announcement from Ribbon Comms is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS missed by $0.00, leading to a 17.22% drop in the share price on the subsequent day.
Here's a look at Ribbon Comms's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.05</td>
<td>0</td>
<td>0.13</td>
<td>0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.05</td>
<td>-0.01</td>
<td>0.12</td>
<td>0.05</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-17.0%</td>
<td>-0.0%</td>
<td>7.000000000000001%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729623769_0.png" alt="eps graph" />
<h3>Tracking Ribbon Comms's Stock Performance</h3>
Shares of Ribbon Comms were trading at $3.4 as of October 21. Over the last 52-week period, shares are up 78.68%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on Ribbon Comms</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Ribbon Comms.
The consensus rating for Ribbon Comms is Buy, derived from 2 analyst ratings. An average one-year price target of $5.0 implies a potential 47.06% upside.
<h3>Analyzing Ratings Among Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Clearfield, Adtran Holdings and Applied Optoelectronics, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>For Clearfield, analysts project an Buy trajectory, with an average 1-year price target of $47.5, indicating a potential 1297.06% upside.</li>
<li>The consensus among analysts is an Buy trajectory for Adtran Holdings, with an average 1-year price target of $7.0, indicating a potential 105.88% upside.</li>
<li>For Applied Optoelectronics, analysts project an Buy trajectory, with an average 1-year price target of $16.2, indicating a potential 376.47% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for Clearfield, Adtran Holdings and Applied Optoelectronics, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ribbon Comms</td>
<td>Buy</td>
<td>-8.55%</td>
<td>$97.87M</td>
<td>-4.05%</td>
</tr>
<tr>
<td>Clearfield</td>
<td>Buy</td>
<td>-20.38%</td>
<td>$10.69M</td>
<td>-0.16%</td>
</tr>
<tr>
<td>Adtran Holdings</td>
<td>Buy</td>
<td>-30.97%</td>
<td>$81.58M</td>
<td>-20.52%</td>
</tr>
<tr>
<td>Applied Optoelectronics</td>
<td>Buy</td>
<td>3.98%</td>
<td>$9.56M</td>
<td>-13.66%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Ribbon Comms ranks at the bottom for Revenue Growth and Gross Profit, indicating lower performance in these areas compared to its peers. However, it ranks in the middle for Return on Equity, suggesting a moderate level of profitability relative to others.
<h3>All You Need to Know About Ribbon Comms</h3>
Ribbon Communications Inc provides network solutions to service providers and enterprises. It enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. It has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.
<h3>Understanding the Numbers: Ribbon Comms's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Ribbon Comms's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -8.55%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -8.73%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Ribbon Comms's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -4.05%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Ribbon Comms's ROA stands out, surpassing industry averages. With an impressive ROA of -1.54%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Ribbon Comms's debt-to-equity ratio is below the industry average. With a ratio of 0.95, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/RBBN/earnings">To track all earnings releases for Ribbon Comms visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RBBN

Ribbon Comms's Earnings: A Preview

ProShares Smart Materials ETF declares quarterly distribution of $0.0911

ProShares Smart Materials ETF declares quarterly distribution of $0.0134

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The second quarter of 2024 is set to be a mixed bag for investors as market growth expectations on Wall Street contend with the Federal Reserve&rsquo;s monetary policy indecision.&nbsp;



At the beginning of the year there was widespread optimism the Fed would cut rates for the first time since Q1 2020, perhaps as early as March. Stubborn inflation levels, however, slowed some of the hopes for clearing this headwind. Now, the prospect of any cuts taking place in the first half of the year <a href="https://www.bloomberg.com/news/articles/2024-04-01/treasury-yields-extend-climb-after-strong-ism-factory-gauges">appears to be evaporating</a>.&nbsp;The cooling market sentiment has caused <a href="https://www.reuters.com/markets/us/futures-nearly-flat-ahead-fed-meet-next-week-2024-03-15/">some chip stocks to decline</a> in recent weeks.&nbsp;



Despite this, the overall outlook for 2024 appears to be bright. Investment giant BlackRock confirmed that <a href="https://www.blackrock.com/us/individual/insights/blackrock-investment-institute/outlook#:~:text=Expectations%20for%20S%26P%20500%20earnings,artificial%20intelligence%20(AI)%20theme.">expectations for S&amp;P 500 earnings growth</a> this year have been revised up, with the tech sector set to account for half of the index&rsquo;s earnings.&nbsp;



This indicates that Q2 2024 may be a little more volatile as markets wait for the Fed to signal how its more dovish stance on monetary policy will play out. Still, many high-potential small-cap stocks can rally throughout the coming months, including the three key candidates highlighted below.&nbsp;



<h2>ACM Research (ACMR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/acmr-stock-1-300x169.jpg" alt="a magnifying glass enlarges the ACM logo on a website"><div>Source: Pavel Kapysh / Shutterstock.com</div></div>Despite a modest market capitalization of around $2 billion, ACM Research (NASDAQ:<a href="https://investorplace.com/stock-quotes/acmr-stock-quote/">ACMR</a>) is a stock that consistently wins the backing of institutional investors.&nbsp;Recently Vanguard Group increased its exposure to the company by <a href="https://www.defenseworld.net/2024/04/07/acm-research-inc-nasdaqacmr-shares-bought-by-vanguard-group-inc.html">adding 399,854 shares</a>, bringing its total holdings to 4,082,835 for a total stake worth $73,920,000.&nbsp;



The strong institutional support also helped its stock rally higher in recent months. Shares grew 81.6% in Q1 2024 and doubled in size during the 2023 calendar year.&nbsp;



As a company with exposure to the booming semiconductor industry, ACM Research&rsquo;s reputation as a cheap growth company has served it well and earned it a &lsquo;strong buy&rsquo; rating from <a href="https://seekingalpha.com/article/4681193-acm-research-undervalued-in-light-of-expected-growth-years">Seeking Alpha&rsquo;s Quant system</a>.&nbsp;



In addition to institutional support, ACMR also boasts strong fundamentals. With a <a href="https://www.fxempire.com/forecasts/article/acm-research-shares-are-under-heavy-accumulation-1413639">three-year sales growth rate of 53%</a> and a three-year earnings-per-share (EPS) growth rate of 62%, there&rsquo;s plenty of optimism flooding into this small-cap stock. The semiconductor equipment maker could see its value continue to rally throughout the second quarter of 2024 and beyond.&nbsp;



<h2>Titan Machinery (TITN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/07/agriculturestocks1600-300x169.jpg" alt="Tractor spraying pesticides on soybean field with sprayer"><div>Source: Shutterstock</div></div>At a market capitalization of $540 million, there appears to be plenty of room for growth for agricultural and construction equipment seller Titan Machinery (NASDAQ:<a href="https://investorplace.com/stock-quotes/titn-stock-quote/">TITN</a>). Consistent growth in company earnings and recent share price underperformance appear to have made the stock an attractive prospect for investors.&nbsp;



For the fourth quarter, Titan&rsquo;s revenue <a href="https://ir.titanmachinery.com/Titan-Machinery-Inc--Announces-Results-for-Fiscal-Fourth-Quarter-and-Full-Year-Ended-January-31--2023-3-16-2023#:~:text=For%20the%20fourth%20quarter%20of,the%20fourth%20quarter%20last%20year.">increased to $583 million</a>, up from the $507.6 million reported in Q4 2022. Gross profit also increased to $108.9 million compared to $94.2 million the previous year.&nbsp;



Despite this, the stock has struggled to build momentum. From a March 2023 peak of $47.17, shares have instead fallen nearly 50% since. Yet the company&rsquo;s current earnings power and a recent series of strategic acquisitions <a href="https://seekingalpha.com/article/4678982-titan-machinery-cheap-enough">make the stock look cheap</a>. Investors may be tempted to back TITN to recapture its early 2023 performance and build a solid recovery starting in this quarter.&nbsp;



According to Titan&rsquo;s <a href="https://simplywall.st/stocks/us/capital-goods/nasdaq-titn/titan-machinery/news/is-it-too-late-to-consider-buying-titan-machinery-inc-nasdaq-1">price-to-earnings (PE) ratio of 4.9x</a>, the company is trading far below its peer average of 13.27x. This highlights that the stock is trading at a lower price than the wider trade distributors industry. As a result, we may see a more optimistic outlook for the firm resulting in stronger institutional interest for the discounted stock. An upturn in wider market fortunes could result in TITN accelerating at a faster pace than other industry players.&nbsp;



<h2>Stride (LRN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/08/online-education-1600-300x169.jpg" alt="a child takes notes while attending an online class. represents education stocks. edtech stocks"><div>Source: Travelerpix / Shutterstock.com</div></div>Thanks to whirlwind growth in 2023, online education firm Stride (NYSE:<a href="https://investorplace.com/stock-quotes/lrn-stock-quote/">LRN</a>) is now trading at a new all-time high following its 2007 debut on the NYSE.&nbsp;



Following growth of around 80% over the past calendar year, the stock has had a cooler start to 2024. However, this hasn&rsquo;t stopped the $2.7 billion market cap firm from positioning itself as an excellent market opportunity for investors.&nbsp;



Impressively, Stride&rsquo;s <a href="https://simplywall.st/stocks/us/consumer-services/nyse-lrn/stride/news/do-strides-nyselrn-earnings-warrant-your-attention-3">earnings-per-share growth of 47%</a> over the past three years illustrates the form that the company has experienced of late and points to a company undergoing a successful scaling operation.



Stride&rsquo;s fundamentals also offer cause for optimism. <a href="https://www.indmoney.com/us-stocks/earnings/lrn-stride-earnings">Revenue grew 10.13%</a> to $504.87 million year-over-year in the fourth quarter, while net profit also grew an impressive 31.81% over the same period to $66.84 million. Crucially, Stride generated a seismic 1,203.15% acceleration in net profit margins between Q3 and Q4 2023.&nbsp;



This has increased optimism for the company, helping to build a steady platform to secure further momentum throughout the quarter ahead and beyond.



On the date of publication, Dmytro Spilka did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Dmytro is a finance and investing writer based in London. He is also the founder of Solvid, Pridicto and Coinprompter. His work has been published in Nasdaq, Kiplinger, FXStreet, Entrepreneur, VentureBeat and InvestmentWeek.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/could-these-3-stocks-be-the-biggest-bargains-of-q2-2024/">Could These 3 Stocks be the Biggest Bargains of Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Comments

ProShares Smart Materials ETF

Intérêt court

ProShares Smart Materials ETF (ARCA:TINT), Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL